ALGORAE PHARMACEUTICALS LIMITED - Announcements

Market Cap $18.56M Add to my watchlist

Healthcare Biotechnology

Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an... Algorae Pharmaceuticals Limited, formerly Living Cell Technologies Limited, is an Australia-based pharmaceutical development company. The Company is focused on discovering and developing novel treatments for medical conditions with under met medical needs. Its programs include AlgoraeOS, Dementia and Parkinson’s. Its drug candidates include NTCELL for Parkinson’s disease and the AI-116 combination drug candidate for dementia. AlgoraeOS is a closed-loop platform, leveraging advanced computational tools to generate novel insights in-silico that are being developed to initiate or accelerate therapeutic programs. The AI-116 is a novel combination drug candidate made up of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The NTCELL is an alginate coated capsule product containing clusters of neonatal porcine choroid plexus cells that are injected into the damaged site within the brain to target the treatment of Parkinson’s disease.More

Announcements

Filter Results

All Price Sensitive Only

1AI	CEO's presentation to AGM		11/11/21	948.63KB	Share
1AI	Chairman's Address to the 2021 Annual General Meeting		11/11/21	158.28KB	Share
1AI	LCT Receives New Zealand R&D Tax Credit	PRICE SENSITIVE	09/11/21	449.56KB	Share
1AI	LCT Advises Price Change for Rights Issue	PRICE SENSITIVE	08/11/21	439.44KB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	29/10/21	1.01MB	Share
1AI	Notice of General Meeting/ Proxy Form		28/10/21	1.4MB	Share
1AI	LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial	PRICE SENSITIVE	26/10/21	538.33KB	Share
1AI	Application for quotation of securities - LCT		20/10/21	24.57KB	Share
1AI	Cleansing Notice		19/10/21	441.68KB	Share
1AI	Proposed issue of securities - LCT		19/10/21	25.29KB	Share
1AI	Secures Funds for 3rd Trial of NTCELL in Parkinson Disease	PRICE SENSITIVE	19/10/21	542.63KB	Share
1AI	Trading Halt	PRICE SENSITIVE	15/10/21	534.46KB	Share
1AI	Pause in Trading	PRICE SENSITIVE	15/10/21	116.88KB	Share
1AI	Appendix 4G and Corporate Governance Statement		08/10/21	740.78KB	Share
1AI	Annual Report to shareholders		08/10/21	8.27MB	Share
1AI	2021 Annual General Meeting		08/10/21	1.42MB	Share
1AI	Notification of cessation of securities - LCT		03/09/21	21.51KB	Share
1AI	Preliminary Final Report and 2021 Financial Statements	PRICE SENSITIVE	31/08/21	1.41MB	Share
1AI	Business Update		16/08/21	440.17KB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	30/07/21	1.03MB	Share
1AI	Appendix 3Z - K Taylor		19/07/21	319KB	Share
1AI	LCT Interim CEO Appointed	PRICE SENSITIVE	16/07/21	430.77KB	Share
1AI	Response to ASX Price Query	PRICE SENSITIVE	02/07/21	821.92KB	Share
1AI	Change of Director's Interest Notice - K Taylor		02/07/21	646.88KB	Share
1AI	Notification of cessation of securities - LCT		02/07/21	21.51KB	Share
1AI	Business Update		10/06/21	430.75KB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	27/04/21	766.89KB	Share
1AI	LCT exits peptide projects	PRICE SENSITIVE	29/03/21	442.51KB	Share
1AI	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/21	1.46MB	Share
1AI	Change in substantial holding		17/02/21	60.76KB	Share
1AI	Change in substantial holding		15/02/21	1.12MB	Share
1AI	Response to ASX Price Query	PRICE SENSITIVE	12/02/21	530.48KB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	28/01/21	729.03KB	Share
1AI	LCT CEO Dr Ken Taylor signals intention to retire	PRICE SENSITIVE	25/01/21	432.48KB	Share
1AI	Correction Notice - Appendix 3G		19/01/21	761.07KB	Share
1AI	Appendix 3G		19/01/21	772.58KB	Share
1AI	Change in substantial holding		13/01/21	61.05KB	Share
1AI	Becoming a substantial holder		27/11/20	58.64KB	Share
1AI	Results of Annual General Meeting		19/11/20	545.23KB	Share
1AI	CEO's presentation to AGM and market update		19/11/20	1.21MB	Share
1AI	Chairman's Address to the 2020 Annual General Meeting		19/11/20	29.89KB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	28/10/20	763.59KB	Share
1AI	Appendix 4G and Corporate Governance Statement		19/10/20	599.34KB	Share
1AI	Annual Report to shareholders		19/10/20	1.07MB	Share
1AI	2020 Annual General Meeting		19/10/20	1.45MB	Share
1AI	Notification of Change of Auditor		18/09/20	429.38KB	Share
1AI	Preliminary Final Report and 2020 Financial Statements	PRICE SENSITIVE	31/08/20	1.43MB	Share
1AI	LCT founder Sir Robert Elliott dies		21/08/20	633.25KB	Share
1AI	Amended Appendix 4C	PRICE SENSITIVE	30/07/20	1.08MB	Share
1AI	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	30/07/20	821.96KB	Share
1AI	Response to ASX Aware Query	PRICE SENSITIVE	13/07/20	715.43KB	Share
1AI	Change of Director's Interest Notice - K Taylor		08/07/20	665.34KB	Share
1AI	LCT Newsletter - July 2020		03/07/20	446.95KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/20	327.47KB	Share
1AI	LCT Covid-19 Business Impact Update		17/04/20	431.54KB	Share
1AI	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/20	1.28MB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/20	321.65KB	Share
1AI	Resignation of Joint Company Secretary		20/12/19	428.88KB	Share
1AI	Response to Appendix 3Y Query		09/12/19	238.37KB	Share
1AI	Change of Director's Interest Notice - K Taylor		06/12/19	206.72KB	Share
1AI	Change of Director's Interest Notice - C Sue		06/12/19	174.97KB	Share
1AI	Appendix 3B		06/12/19	429.9KB	Share
1AI	Appendix 3X - A Kelly		11/11/19	267.29KB	Share
1AI	Appendix 3Z - L Hunter		11/11/19	339.14KB	Share
1AI	Dr Andrew Kelly joins LCT board		08/11/19	498.85KB	Share
1AI	Results of Annual General Meeting		07/11/19	446.19KB	Share
1AI	CEO's presentation to AGM and market update		07/11/19	592.66KB	Share
1AI	Chairman's Address to the 2019 Annual General Meeting		07/11/19	59.86KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/19	1.07MB	Share
1AI	LCT extends cash runway with receipt from Vertex acquisition	PRICE SENSITIVE	16/10/19	75.9KB	Share
1AI	Appendix 4G and Corporate Governance Statement		04/10/19	312.05KB	Share
1AI	Annual Report to shareholders		04/10/19	2.64MB	Share
1AI	Notice of Annual General Meeting/Proxy Form		04/10/19	2.61MB	Share
1AI	Becoming a substantial holder		27/09/19	238.25KB	Share
1AI	LCT to benefit from Semma Therapeutics acquisition by Vertex	PRICE SENSITIVE	19/09/19	83.49KB	Share
1AI	Response to ASX Aware Query	PRICE SENSITIVE	17/09/19	471.52KB	Share
1AI	Notice received under s203D & s249N of the Corporations Act		10/09/19	87.66KB	Share
1AI	Living Insights Newsletter September 2019		09/09/19	377.96KB	Share
1AI	Preliminary Final Report and 2019 Financial Statements	PRICE SENSITIVE	29/08/19	698.61KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	26/07/19	310.08KB	Share
1AI	NTCELL Parkinsons trial 2 year data analysis shows success		23/07/19	125.87KB	Share
1AI	Appendix 3X - Carolyn Sue		16/05/19	821.21KB	Share
1AI	NTCELL Parkinsons trial patient data 2 years after implant	PRICE SENSITIVE	13/05/19	457.82KB	Share
1AI	LCT board changes		07/05/19	462.36KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	15/04/19	691.72KB	Share
1AI	CEO presentation to Phar East conference, Singapore		08/03/19	1.4MB	Share
1AI	Living Insights Newsletter February 2019		01/03/19	459.42KB	Share
1AI	Half Yearly Report and Accounts	PRICE SENSITIVE	19/02/19	850.35KB	Share
1AI	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/19	698.49KB	Share
1AI	NTCELL Phase I IIa Parkinson's trial update		21/01/19	459.35KB	Share
1AI	Change of Director's Interest Notice - R Willcocks		13/12/18	436.43KB	Share
1AI	Change of Director's Interest Notice - K Taylor		13/12/18	674.86KB	Share
1AI	Change of Director's Interest Notice - L Hunter		13/12/18	453.18KB	Share
1AI	Change of Director's Interest Notice - R Elliott		13/12/18	452.51KB	Share
1AI	Change of Director's Interest Notice - B Tuch		13/12/18	453.32KB	Share
1AI	Appendix 3B - Unquoted options		13/12/18	838.93KB	Share
1AI	Results of Annual General Meeting		15/11/18	578.91KB	Share
1AI	CEO Presentation to the 2018 Annual General Meeting		15/11/18	1.72MB	Share
1AI	Chairman's Address to the 2018 Annual General Meeting		15/11/18	287.13KB	Share
1AI	Change of Director's Interest Notice - R Elliott		07/11/18	249.54KB	Share

1AI CEO's presentation to AGM
11/11/21		948.63KB	Share
1AI Chairman's Address to the 2021 Annual General Meeting
11/11/21		158.28KB	Share
1AI LCT Receives New Zealand R&D Tax Credit
09/11/21	PRICE SENSITIVE	449.56KB	Share
1AI LCT Advises Price Change for Rights Issue
08/11/21	PRICE SENSITIVE	439.44KB	Share
1AI Quarterly Activity Report and Appendix 4C
29/10/21	PRICE SENSITIVE	1.01MB	Share
1AI Notice of General Meeting/ Proxy Form
28/10/21		1.4MB	Share
1AI LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial
26/10/21	PRICE SENSITIVE	538.33KB	Share
1AI Application for quotation of securities - LCT
20/10/21		24.57KB	Share
1AI Cleansing Notice
19/10/21		441.68KB	Share
1AI Proposed issue of securities - LCT
19/10/21		25.29KB	Share
1AI Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
19/10/21	PRICE SENSITIVE	542.63KB	Share
1AI Trading Halt
15/10/21	PRICE SENSITIVE	534.46KB	Share
1AI Pause in Trading
15/10/21	PRICE SENSITIVE	116.88KB	Share
1AI Appendix 4G and Corporate Governance Statement
08/10/21		740.78KB	Share
1AI Annual Report to shareholders
08/10/21		8.27MB	Share
1AI 2021 Annual General Meeting
08/10/21		1.42MB	Share
1AI Notification of cessation of securities - LCT
03/09/21		21.51KB	Share
1AI Preliminary Final Report and 2021 Financial Statements
31/08/21	PRICE SENSITIVE	1.41MB	Share
1AI Business Update
16/08/21		440.17KB	Share
1AI Quarterly Activity Report and Appendix 4C
30/07/21	PRICE SENSITIVE	1.03MB	Share
1AI Appendix 3Z - K Taylor
19/07/21		319KB	Share
1AI LCT Interim CEO Appointed
16/07/21	PRICE SENSITIVE	430.77KB	Share
1AI Response to ASX Price Query
02/07/21	PRICE SENSITIVE	821.92KB	Share
1AI Change of Director's Interest Notice - K Taylor
02/07/21		646.88KB	Share
1AI Notification of cessation of securities - LCT
02/07/21		21.51KB	Share
1AI Business Update
10/06/21		430.75KB	Share
1AI Quarterly Activity Report and Appendix 4C
27/04/21	PRICE SENSITIVE	766.89KB	Share
1AI LCT exits peptide projects
29/03/21	PRICE SENSITIVE	442.51KB	Share
1AI Half Yearly Report and Accounts
25/02/21	PRICE SENSITIVE	1.46MB	Share
1AI Change in substantial holding
17/02/21		60.76KB	Share
1AI Change in substantial holding
15/02/21		1.12MB	Share
1AI Response to ASX Price Query
12/02/21	PRICE SENSITIVE	530.48KB	Share
1AI Quarterly Activity Report and Appendix 4C
28/01/21	PRICE SENSITIVE	729.03KB	Share
1AI LCT CEO Dr Ken Taylor signals intention to retire
25/01/21	PRICE SENSITIVE	432.48KB	Share
1AI Correction Notice - Appendix 3G
19/01/21		761.07KB	Share
1AI Appendix 3G
19/01/21		772.58KB	Share
1AI Change in substantial holding
13/01/21		61.05KB	Share
1AI Becoming a substantial holder
27/11/20		58.64KB	Share
1AI Results of Annual General Meeting
19/11/20		545.23KB	Share
1AI CEO's presentation to AGM and market update
19/11/20		1.21MB	Share
1AI Chairman's Address to the 2020 Annual General Meeting
19/11/20		29.89KB	Share
1AI Quarterly Activity Report and Appendix 4C
28/10/20	PRICE SENSITIVE	763.59KB	Share
1AI Appendix 4G and Corporate Governance Statement
19/10/20		599.34KB	Share
1AI Annual Report to shareholders
19/10/20		1.07MB	Share
1AI 2020 Annual General Meeting
19/10/20		1.45MB	Share
1AI Notification of Change of Auditor
18/09/20		429.38KB	Share
1AI Preliminary Final Report and 2020 Financial Statements
31/08/20	PRICE SENSITIVE	1.43MB	Share
1AI LCT founder Sir Robert Elliott dies
21/08/20		633.25KB	Share
1AI Amended Appendix 4C
30/07/20	PRICE SENSITIVE	1.08MB	Share
1AI Quarterly Activity Report and Appendix 4C
30/07/20	PRICE SENSITIVE	821.96KB	Share
1AI Response to ASX Aware Query
13/07/20	PRICE SENSITIVE	715.43KB	Share
1AI Change of Director's Interest Notice - K Taylor
08/07/20		665.34KB	Share
1AI LCT Newsletter - July 2020
03/07/20		446.95KB	Share
1AI Appendix 4C - quarterly
29/04/20	PRICE SENSITIVE	327.47KB	Share
1AI LCT Covid-19 Business Impact Update
17/04/20		431.54KB	Share
1AI Half Yearly Report and Accounts
27/02/20	PRICE SENSITIVE	1.28MB	Share
1AI Appendix 4C - quarterly
30/01/20	PRICE SENSITIVE	321.65KB	Share
1AI Resignation of Joint Company Secretary
20/12/19		428.88KB	Share
1AI Response to Appendix 3Y Query
09/12/19		238.37KB	Share
1AI Change of Director's Interest Notice - K Taylor
06/12/19		206.72KB	Share
1AI Change of Director's Interest Notice - C Sue
06/12/19		174.97KB	Share
1AI Appendix 3B
06/12/19		429.9KB	Share
1AI Appendix 3X - A Kelly
11/11/19		267.29KB	Share
1AI Appendix 3Z - L Hunter
11/11/19		339.14KB	Share
1AI Dr Andrew Kelly joins LCT board
08/11/19		498.85KB	Share
1AI Results of Annual General Meeting
07/11/19		446.19KB	Share
1AI CEO's presentation to AGM and market update
07/11/19		592.66KB	Share
1AI Chairman's Address to the 2019 Annual General Meeting
07/11/19		59.86KB	Share
1AI Appendix 4C - quarterly
24/10/19	PRICE SENSITIVE	1.07MB	Share
1AI LCT extends cash runway with receipt from Vertex acquisition
16/10/19	PRICE SENSITIVE	75.9KB	Share
1AI Appendix 4G and Corporate Governance Statement
04/10/19		312.05KB	Share
1AI Annual Report to shareholders
04/10/19		2.64MB	Share
1AI Notice of Annual General Meeting/Proxy Form
04/10/19		2.61MB	Share
1AI Becoming a substantial holder
27/09/19		238.25KB	Share
1AI LCT to benefit from Semma Therapeutics acquisition by Vertex
19/09/19	PRICE SENSITIVE	83.49KB	Share
1AI Response to ASX Aware Query
17/09/19	PRICE SENSITIVE	471.52KB	Share
1AI Notice received under s203D & s249N of the Corporations Act
10/09/19		87.66KB	Share
1AI Living Insights Newsletter September 2019
09/09/19		377.96KB	Share
1AI Preliminary Final Report and 2019 Financial Statements
29/08/19	PRICE SENSITIVE	698.61KB	Share
1AI Appendix 4C - quarterly
26/07/19	PRICE SENSITIVE	310.08KB	Share
1AI NTCELL Parkinsons trial 2 year data analysis shows success
23/07/19		125.87KB	Share
1AI Appendix 3X - Carolyn Sue
16/05/19		821.21KB	Share
1AI NTCELL Parkinsons trial patient data 2 years after implant
13/05/19	PRICE SENSITIVE	457.82KB	Share
1AI LCT board changes
07/05/19		462.36KB	Share
1AI Appendix 4C - quarterly
15/04/19	PRICE SENSITIVE	691.72KB	Share
1AI CEO presentation to Phar East conference, Singapore
08/03/19		1.4MB	Share
1AI Living Insights Newsletter February 2019
01/03/19		459.42KB	Share
1AI Half Yearly Report and Accounts
19/02/19	PRICE SENSITIVE	850.35KB	Share
1AI Appendix 4C - quarterly
30/01/19	PRICE SENSITIVE	698.49KB	Share
1AI NTCELL Phase I IIa Parkinson's trial update
21/01/19		459.35KB	Share
1AI Change of Director's Interest Notice - R Willcocks
13/12/18		436.43KB	Share
1AI Change of Director's Interest Notice - K Taylor
13/12/18		674.86KB	Share
1AI Change of Director's Interest Notice - L Hunter
13/12/18		453.18KB	Share
1AI Change of Director's Interest Notice - R Elliott
13/12/18		452.51KB	Share
1AI Change of Director's Interest Notice - B Tuch
13/12/18		453.32KB	Share
1AI Appendix 3B - Unquoted options
13/12/18		838.93KB	Share
1AI Results of Annual General Meeting
15/11/18		578.91KB	Share
1AI CEO Presentation to the 2018 Annual General Meeting
15/11/18		1.72MB	Share
1AI Chairman's Address to the 2018 Annual General Meeting
15/11/18		287.13KB	Share
1AI Change of Director's Interest Notice - R Elliott
07/11/18		249.54KB	Share

REFRESH

First 2 3 4 5 6

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $18.56M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.1¢	$117	10.41K

Buyers (Bids)

No.	Vol.	Price($)
7	1917185	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	1078999	5

View Market Depth

No.	Vol.	Price($)
7	1917185	0.011
10	4684067	0.010
15	8312896	0.009
6	767959	0.008
7	6280009	0.007

Price($)	Vol.	No.
0.012	1078999	5
0.013	3093333	5
0.014	1522818	4
0.015	699995	3
0.016	1394000	2

Last trade - 13.25pm 28/05/2024 (20 minute delay)


Last 1.1¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
1.1¢	1.1¢	1.1¢	1000000
Last updated 13.25pm 28/05/2024 ?

1AI (ASX) Chart

ALGORAE PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories